Two years into pandemic, we’re better prepared to fight off virus variants
By
Alicia Lasek
Dec 02, 2021
Despite the threat of the quickly spreading and highly mutated omicron coronavirus variant — which has just landed in the U.S. — we are safer than we were before the pandemic, some experts say.
Driven by pandemic lessons, CDC advisers mull endorsing high-dose flu vaccines for seniors
By
Alicia Lasek
Mar 15, 2022
A decision to recommend high-dose influenza shots over standard-dose vaccines would be a welcome change, long-term care stakeholders say.
New ‘weapon in our arsenal’: Antibody drug cuts COVID risk by 80 percent in LTC residents
By
Alicia Lasek
Jan 22, 2021
Staff and residents who received Eli Lilly’s monoclonal antibody therapy were less likely to contract symptomatic COVID-19 than placebo groups in a late-stage trial. Industry advocates are hailing...
SNF physicians’ unique skill set requires more definition and support, industry docs say
By
Alicia Lasek
Apr 15, 2022
Insights into these doctors’ contributions and constraints are highlighted in interviews with medical directors and attending physicians.
Long-term care providers who’ve been flummoxed about recent infection control guidance coming from federal health agencies are not alone.
All nursing home staff in Massachusetts must get COVID-19 shots
By
Alicia Lasek
Aug 05, 2021
The state is requiring staff and contract employees in all of its 378 facilities to receive a vaccination, Gov. Charlie Baker announced Wednesday.
Rollout of COVID antibody therapy requires clinician feedback, U.S. officials say
By
Alicia Lasek
Nov 11, 2020
Federal agencies say they will depend on clinician input during distribution of Eli Lilly’s new intravenous antibody therapy for high-risk COVID-19 patients.